| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | RVI BIOTECNOLOGÍA | 22,10% | 67,36% | 50,82% | · |
| GROUPAMA EURO ACTIVE EQUITY IC | RV EURO | 8,18% | 51,94% | 50,82% | 139,87% |
| BGF EMERGING MARKETS EQUITY INCOME I2 CHF (HEDGED) | RVI EMERGENTES | 23,93% | 82,93% | 50,81% | 128,21% |
| JPM US VALUE D (ACC) USD | RVI USA VALOR | 21,27% | 44,42% | 50,81% | 138,43% |
| UBS (LUX) EQUITY SICAV - LONG TERM THEMES (USD) F-ACC | RVI GLOBAL | 17,58% | 51,05% | 50,81% | · |
| UBS MSCI CANADA UCITS ETF HGBP DIS | RVI CANADA | 21,01% | 63,16% | 50,81% | 115,16% |
| BNP PARIBAS ASIA EX-JAPAN EQUITY I EUR CAP | RVI ASIA EX-JAPÓN | 36,01% | 89,95% | 50,79% | 119,42% |
| SCHRODER ISF EMERGING MARKETS EQUITY ALPHA C ACC USD | RVI EMERGENTES VALOR | 27,78% | 81,36% | 50,79% | · |
| BGF WORLD MINING C2 EUR (HEDGED) | RVI MATERIAS PRIMAS | 20,37% | 70,29% | 50,78% | 143,28% |
| CAPITAL GROUP NEW PERSPECTIVE FUND (LUX) A4 USD | RVI GLOBAL | 11,87% | 56,96% | 50,78% | 233,19% |
